Thromb Haemost 1979; 41(04): 677-686
DOI: 10.1055/s-0038-1646825
Original Articles
Schattauer GmbH Stuttgart

Separation of Fibrinogen Degradation Products (FDP) by Means of Adsorption to Insolubilized Fibrinmonomer (FM-ag)[*]

D L Heene
The Department of Medicine, Justus Liebig-University Giessen, D-6300 Giessen, West-Germany
,
F R Matthias
The Department of Medicine, Justus Liebig-University Giessen, D-6300 Giessen, West-Germany
,
Z Wegrzynowicz
The Department of Medicine, Justus Liebig-University Giessen, D-6300 Giessen, West-Germany
,
G Hocke
The Department of Medicine, Justus Liebig-University Giessen, D-6300 Giessen, West-Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Summary

The phenomenon of complex formation between fibrinmonomer and fibrinogen degradation products was investigated by means of adsorption of FDP to insolubilized thrombin- modified fibrinogen (FM-ag). Since it could be demonstrated that there are different adsorption characteristics for early FDP and late FDP, the possibility of separation of FDP by means of affinity chromatography on FM-ag columns was evaluated using plasmic digests of 3H-Ac-labelled fibrinogen. The identification of FDP was performed by disc-electrophoresis. The results indicate that the adsorption of early FDP is comparable to the behaviour of fibrinogen, whereas late FDP show essential difference in the affinity towards FM-ag, evident by the result that fragment E adsorbs only to a minimal extent. Fragments D and E derived from fibrinogen as well as from non-crosslinked fibrin, revealed identical adsorption characteristics. Under specified conditions the procedure is suitable as a preparative method for the separation of fragments D and E.

* Presented at the workshop on “Shape and Structure of Fibrinogen” Martinsried, March 19,1977


 
  • References

  • 1 Collen D, Semeraro N, Verstraete M. 1974; The fibrinogenolytic pathway of fibrinogen catabolism: a reply. Thrombosis Research 4: 491
  • 2 Heene DL, Matthias FR. 1973; Adsorption of fibrinogen derivatives on insolubilized fibrinogen and fibrinmonomer. Thrombosis Research 2: 137
  • 3 Kekwick RA, Mackay ME, Nance MH, Record BR. 1955; The purification of human fibrinogen. Biochemical Journal 60: 671
  • 4 Kudryk B, Reuterby J, Blombäck B. 1973; Adsorption of plasmic fragment D to thrombin modified fibrinogen Sepharose. Thrombosis Research 2: 291
  • 5 Kudryk B, Collen D, Woods KR, Blombäck B. 1974; Evidence for localization of polymerization sites in fibrinogen. Journal of Biology and Chemistry 249: 3322
  • 6 Marder VJ, Shulman NR, Carroll WR. 1969; High molecular weight derivatives of human fibrinogen produces by plasmin. I. Physiocochemical and immunological characterization Journal of Biological Chemistry 244: 2111
  • 7 Matthias FR, Heene DL, Konradi E. 1973; Behaviour of fibrinogen and fibrinogen degradation products (FDP) towards insolubilized fibrinogen and fibrinmonomer. Thrombosis Research 3: 657
  • 8 Matthias FR, Heene DL. 1973; Comparative adsorption studies between fibrinogen and its degradation products and fibrinmonomer produced by reptilase and thrombin. Thrombosis Research 3: 745
  • 9 Plow EF, Edington TS. 1974; The number of D and E regions in the fibrinogen molecule. Proceedings of the National Academy of Sciences USA 71: 158
  • 10 Stathakis NE, Mosesson MW. 1977; Interactions among heparin, cold insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma. Journal of Clinical Investigation 60: 855
  • 11 Stemberger A, Hörmann H. 1975; Heterogeneity of clottable fibrinogen isolated from plasma by affinity chromatography. Hoppe-Seyler’s Zeitschrift für Physiologische Chemie 356: 341
  • 12 Swank RT, Munkres KD. 1971; Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium-dodecyl-sulfate. Analytical Biochemistry 39: 462
  • 13 Wegrzynowicz Z, Kloczewiak M, Kopec M. 1975; Bovine fibrinogen modified with3H.acetic anhydride (3H-AcOAc). Journal of Laboratory and Clinical Medicine 86: 360